Announcements Trials
Browse Landscape

Status

Completed 92Recruiting 47Terminated 23Unknown 22Active not recruiting 16Withdrawn 4Not yet recruiting 3Available 2Approved for marketing 2Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 4Gynecologic 4Genitourinary 4Sarcoma 3CNS 3Head & Neck 2Dermatologic 2Breast 2Lymphoid 1

Conditions

Head and Neck Neoplasms 3Pancreatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Stomach Neoplasms 1Recurrence 1Parathyroid Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Melanoma 1Glioblastoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease 1Colorectal Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

ulixertinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Available × Pancreatic Neoplasms × Head & Neck × Clear all
NCT04566393 2026-06-04

Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies

xCures

Available
CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioblastoma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06872489 2025-07-23

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Second Life Therapeutics

Available
CNSGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡